Jiangbo Chen
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
STK25 inhibits cancer-associated fibroblast activation to overcome cetuximab resistance in colorectal cancer.
Journal: Clinical and translational medicine
Published: December 29, 2025
STK25 Loss Augments Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Stability in Colorectal Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 02, 2025
Multi-omic profiling identifies KRT1 as a predictor of immune infiltration and prognosis in gastroesophageal junction cancer.
Journal: Functional & integrative genomics
Published: January 14, 2025
MTCH2 Deficiency Promotes E2F4/TFRC-Mediated Ferroptosis and Sensitizes Colorectal Cancer Liver Metastasis to Sorafenib.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 01, 2025
Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer.
Journal: Cancer cell international
Published: March 22, 2024
Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer.
Journal: Computers in biology and medicine
Published: October 11, 2022
Downregulation of STK25 promotes autophagy via the Janus kinase 2/signal transducer and activator of transcription 3 pathway in colorectal cancer.
Journal: Molecular carcinogenesis
Published: December 16, 2021
A stop-gain mutation in GXYLT1 promotes metastasis of colorectal cancer via the MAPK pathway.
Journal: Cell death & disease
Published: October 18, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026